Recent news on Humulin R

Bentley Late Breaking Abstract Accepted for Poster Presentation at ...  -  May 24, 2007
PharmaLive.com (press release),Single-Dose, 4-Way Crossover, Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin(TM)), Injectable Regular Insulin (Humulin R(R)),

Insulin therapy for diabetes  -  May 16, 2007
Chennai Online,Regular short-acting insulins: These constitute the synthetic human insulins such as Humulin R and Novolin R which are zinc-insulin crystalline suspensions

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Genetic Engineering News (press release),Zyprexa(R) $1108.0 $1007.4 10% Cymbalta 441.8 233.3 89% Gemzar(R) 376.9 338.8 11% Humalog(R) 339.5 304.5 11% Evista(R) 263.8 241.6 9% Humulin(R) 225.8

Nasulin Interim Results to Be Presented at American Diabetes ...  -  Apr 10, 2007
PharmaLive.com (press release),Single-Dose, 4-Way Crossover, Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin(TM)), Injectable Regular Insulin (Humulin R(R)),

Nasulin™ Interim Results to Be Presented at American Diabetes ...  -  Apr 10, 2007
Business Wire (press release),Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin™), Injectable Regular Insulin (Humulin R®), Injectable Fast-Acting Insulin (Humalog®),

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Drug Newswire (press release),In the fourth quarter of 2006, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos and Byetta, increased 4 percent, to $781.7 million

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
MSN MoneyDiabetes Care Products In the fourth quarter of 2006, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos and Byetta,

Feline diabetes can be treated  -  Feb 15, 2007
Tahlequah Daily Press,...hormone – preferably the long-lasting varieties like Humulin N, as opposed to the fast-acting insulins like Humulin R – will still work fine for cats.

SemBioSys' plant-produced insulin chemically and physiologically ...  -  18 Jan 2007
Drug Newswire (press release),...significant difference in the pharmacodynamic response of safflower-produced insulin in comparison to Eli Lilly's Humulin(R) and USP insulin treatments.

SemBioSys' Plant-Produced Insulin Chemically and Physiologically ...  -  Jan 10, 2007
Juraforum.de,...significant difference inthe pharmacodynamic response of safflower-produced insulin incomparison to Eli Lilly's Humulin(R) and USP insulin treatments.

Family seeks $50M in wrongful death suit  -  Dec 7, 2006
Frederick News Post (subscription),Also diabetic, Kraig Scofield was with his brother in December 2005 when Keith Scofield went to Wal-Mart to buy Humulin R (u-100), a drug available without

Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS ...  Oct 24, 2006
Diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and Byetta, increased 9 percent, to $712.4 million, compared with the third ... -Drug Newswire (press release), Targanta Announces Additions to Management Team  Aug 24, 2006
Mr. Miller has worked on leading brands such as Vancocin(R), Tylosin(R), Coban(R), Keflex(R), Ceclor(R), Prozac(R), and Humulin(R). He later returned to Lilly ... -PR Newswire

Family seeks $50M in wrongful death suit  -  Dec 7, 2006
Frederick News Post (subscription),Also diabetic, Kraig Scofield was with his brother in December 2005 when Keith Scofield went to Wal-Mart to buy Humulin R (u-100), a drug available without

Targanta Announces Additions to Management Team  Aug 24, 2006
Mr. Miller has worked on leading brands such as Vancocin(R), Tylosin(R), Coban(R), Keflex(R), Ceclor(R), Prozac(R), and Humulin(R). He later returned to Lilly ... -International News Service

Lilly Reports Second-Quarter EPS of $.76  Jul 21, 2006
Diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and Byetta, increased 5 percent, to $701.7 million, compared with the second ... -Finanzen.net



Clinician Presents Generex Oral-lyn(TM) Clinical Data at the ...  May 2, 2006
...to the podium presentation, Dr. Guevara made a poster presentation at the symposium of a study entitled "A 12-Day Comparison of Preprandial Humulin-R® vs. ... - Market Wire

Lilly Reports Q1 EPS of $.77, or 13% Growth  Apr 20, 2006
Diabetes care revenue, composed primarily of Humalog, Humulin(R), Actos(R) and recently launched Byetta, increased 5 percent, to $763.4 million, compared with ... - MSN Money



Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...  Jan 26, 2006
Diabetes Care Products In the fourth quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and recently launched Byetta ... - PR Newswire

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...  Jan 26, 2006
In the fourth quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and recently launched Byetta, increased 11 percent ... - Finanzen.net

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional